New bendable tube could make heart valve surgery safer
NCT ID NCT07320274
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests a new device called the ArcFlex Sheath, a bendable tube used during TAVR surgery to replace a faulty aortic valve. The goal is to see if it helps doctors position the new valve more easily and safely compared to a standard sheath. About 180 people who need TAVR surgery will take part. The study will measure how often the surgery is successful and track survival rates at 30 days and one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ArcFlex Sheath (a bendable tube used during heart valve replacement surgery)
What this could lead to
If it works, this could make TAVR heart valve surgery safer and more successful by helping doctors position the new valve more easily.
What could go wrong
This is an early-stage device trial with only 180 people, so results may not apply to everyone. There are always risks with any new surgical tool, such as damage to blood vessels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VALVE DISEASE, AORTIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••